Spots Global Cancer Trial Database for genital diseases, male
Every month we try and update this database with for genital diseases, male cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | NCT00672009 | Prostatic Disea... Genital Neoplas... Urogenital Neop... Genital Disease... Adenocarcinoma Prostatic Neopl... Neoplasms, Glan... Carcinoma | Ixabepilone | - | Cedars-Sinai Medical Center | |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy | NCT04461509 | Prostatic Neopl... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Genital Disease... Prostatic Disea... | 18F-PSMA | 18 Years - | Cedars-Sinai Medical Center | |
| Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer | NCT04597411 | Prostatic Neopl... | 225^Ac-PSMA-617 68^Ga-PSMA-11 | 18 Years - | Endocyte | |
| A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study | NCT02578797 | Castration-Resi... | Apalutamide | 18 Years - | Aragon Pharmaceuticals, Inc. | |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy | NCT01316458 | Prostatic Neopl... Genital Neoplas... Neoplasms, Abdo... Urogenital Neop... Genital Disease... Prostatic Disea... Antineoplastic ... Imatinib | STI571 (Glivec®... | 18 Years - | Novartis | |
| A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) | NCT00749502 | Solid Tumors Chronic Lymphoc... T-cell-prolymph... | MK-4827 | 18 Years - | Tesaro, Inc. | |
| Health Gatherings - For Your Health After Cancer | NCT03344757 | Prostate Neopla... Genital Neoplas... Urogenital Neop... Neoplasm, Prost... Genital Disease... Prostatic Disea... | Cultural CBSM Standard CBSM | 18 Years - | University of Miami | |
| Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer | NCT01217697 | Prostate Neopla... Genital Neoplas... Urogenital Neop... Genital Disease... | Abiraterone Ace... Prednisone\Pred... | 18 Years - 99 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy | NCT01316458 | Prostatic Neopl... Genital Neoplas... Neoplasms, Abdo... Urogenital Neop... Genital Disease... Prostatic Disea... Antineoplastic ... Imatinib | STI571 (Glivec®... | 18 Years - | Novartis | |
| Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer | NCT06190899 | mCRPC (Metastat... Genital Disease... Urogenital Dise... Prostatic Disea... Prostatic Neopl... Prostate Cancer | Gedatolisib Darolutamide | 18 Years - | Celcuity Inc | |
| Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer | NCT02049190 | Prostate Cancer Metastatic Pros... Androgen-indepe... Recurrent Prost... | onapristone abiraterone | 18 Years - | Arno Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
